Evaluating ketorolac for treating upper extremity joint and tendon pain
Official title: Single Blind RCT to Evaluate the Effect of Ketorolac in Upper Extremity Tendinopathy and Arthropathy
Run by Emory University · NCT05292339 · Data updated 2026-11-12
This study is testing whether ketorolac or triamcinolone injections can help people with joint and tendon pain in their shoulders, elbows, wrists, and hands feel better and improve their function.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Emory University Academic / other |
| Locations | 4 sites (Atlanta, Georgia and 3 other locations) |
| Status | Recruiting |
| Started | January 31, 2023 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT05292339 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with symptomatic upper extremity tendinopathy or arthropathy who have not had prior surgical treatment.
✕Probably not a fit
Patients under 18, those who have had recent injections, or those with active infections or contraindications to the medications will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the effectiveness of ketorolac and triamcinolone injections for patients suffering from tendinopathy and arthropathy in the shoulder, elbow, wrist, and hand. Participants will receive either injection type and will be monitored over a 24-week period to evaluate pain relief and functional improvement. The study employs a blinded approach to ensure unbiased results regarding the efficacy of these treatments. It addresses a gap in existing research concerning the management of smaller joint conditions compared to larger joints.
Why it matters
Potential benefit: If successful, this study could provide a new effective treatment option for patients with upper extremity pain due to tendinopathy and arthropathy.
How similar studies have gone: While there is existing research on corticosteroid injections for larger joints, studies specifically evaluating ketorolac for smaller joint conditions are limited, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 or older, * symptomatic tendinopathy or arthropathy of the shoulder, elbow, hand, or wrist who have not undergone prior surgical treatment for their condition. * Diagnoses may include trigger finger, De Quervain's tenosynovitis, radiocarpal osteoarthritis, first carpometacarpal (CMC) joint osteoarthritis, metacarpophalangeal joint osteoarthritis, or proximal interphalangeal joint osteoarthritis. Exclusion Criteria: * Patients under the age of 18, * Patients who have undergone prior triamcinolone or ketorolac injections within the past 6 months, * Patients who have undergone prior surgical treatment for their hand condition, * Patients with allergy or contraindication to triamcinolone or ketorolac injection, * Patients with an active infection at the treatment site \[active infection defined as cellulitis, purulence, fever, chills, or presence of elevated inflammatory markers, ie. white blood cells (WBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)\].
Where it's running
-
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States Recruiting -
Emory University Orthopaedic and Spine Center
Atlanta, Georgia, United States Recruiting -
12 Executive Park Drive
Atlanta, Georgia, United States Recruiting -
Emory University Orthopaedic and Spine Hospital
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Paul A. Ghareeb, MD — Emory University
- Study coordinator: Paul A. Ghareeb, MD
- Email: paul.ghareeb@emory.edu
- Phone: 404-778-3350
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vibration or cool-spray to reduce pain from steroid injections in the hand and wrist
This trial tests whether vibration or vapocoolant spray makes corticosteroid injections in the hands, wrists, or elbows less painful for adults with arthritis, tendinopathy, or nerve compression.
-
Antigravity treadmill rehabilitation after hip or knee replacement
This project will test whether antigravity or body-weight-supported treadmill training helps people aged 60–75 recover walking, balance, and confidence after hip or knee replacement.
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Early wear of a Vitamin E-infused liner in a dual-mobility hip replacement
This study tests whether a Vitamin E-infused liner in a dual-mobility hip implant wears as little as a conventional liner over two years in adults needing hip replacement.
-
Preoperative Music to Ease Anxiety Before Hip or Knee Replacement
Patients awaiting hip or knee replacement listen to their own music through noise‑canceling headphones to see if it lowers preoperative anxiety.
-
Hyaluronic Acid vs Platelet-R-rich Plasma for Chronic Tendinopathy and Enthesopathy
This study tests whether injections of hyaluronic acid or autologous platelet-rich plasma can help people with chronic tendon and enthesis problems in the elbow or Achilles area.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.